文献速递心境障碍

抑郁症中生长抑素阳性GABA中间神经元缺陷:皮层微环路与治疗视角

Somatostatin-Positive Gamma-Aminobutyric Acid Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives.
PubMed 文献 · Biol Psychiatry · 2017-06-08

本文综述了GABA能抑制功能降低在重性抑郁障碍(MDD)等多种神经精神障碍中的证据,重点指出MDD中选择性易损的共表达生长抑素(SST)的GABA能中间神经元。文章探讨了SST中间神经元在皮层加工和行为控制中的作用,并讨论了SST细胞缺陷的可能起源及治疗意义。

要点

  • MDD中SST阳性GABA能中间神经元选择性易损,参与皮层微环路调控。
  • SST中间神经元缺陷是MDD的细胞病理贡献,为治疗干预的潜在靶点。

核心结论

  • SST中间神经元缺陷是MDD中导致抑制功能异常的细胞病理因素,也是恢复正常抑制功能的潜在治疗靶点。

主要发现

  • 多种神经精神障碍(包括MDD、双相障碍、焦虑障碍和精神分裂症)中抑制性GABA水平与功能降低。
  • MDD的人脑死后和动物研究证据提示共表达生长抑素的GABA能中间神经元选择性易损。
  • SST中间神经元参与调节锥体细胞兴奋性输入以及情绪和认知等行为控制。

临床怎么用

  • SST中间神经元可作为改善MDD抑制功能异常的潜在治疗靶点,但尚需进一步临床验证。

局限性

  • 本文为综述,未报告原始研究的具体样本量、效应量或统计阈值等数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The functional integration of external and internal signals forms the basis of information processing and is essential for higher cognitive functions. This occurs in finely tuned cortical microcircuits whose functions are balanced at the cellular level by excitatory glutamatergic pyramidal neurons and inhibitory gamma-aminobutyric acidergic (GABAergic) interneurons. The balance of excitation and inhibition, from cellular processes to neural network activity, is characteristically disrupted in multiple neuropsychiatric disorders, including major depressive disorder (MDD), bipolar disorder, anxiety disorders, and schizophrenia. Specifically, nearly 3 decades of research demonstrate a role for reduced inhibitory GABA level and function across disorders. In MDD, recent evidence from human postmortem and animal studies suggests a selective vulnerability of GABAergic interneurons that coexpress the neuropeptide somatostatin (SST). Advances in cell type-specific molecular genetics have now helped to elucidate several important roles for SST interneurons in cortical processing (regulation of pyramidal cell excitatory input) and behavioral control (mood and cognition). Here, we review evidence for altered inhibitory function arising from GABAergic deficits across disorders and specifically in MDD. We then focus on properties of the cortical microcircuit, where SST-positive GABAergic interneuron deficits may disrupt functioning in several ways. Finally, we discuss the putative origins of SST cell deficits, as informed by recent research, and implications for therapeutic approaches. We conclude that deficits in SST interneurons represent a contributing cellular pathology and therefore a promising target for normalizing altered inhibitory function in MDD and other disorders with reduced SST cell and GABA functions.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Fee C, Banasr M, Sibille E, et al. Somatostatin-Positive Gamma-Aminobutyric Acid Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives. Biol Psychiatry. 2017. PMID: 28697889. doi:10.1016/j.biopsych.2017.05.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。